Evernest Financial Advisors Rebalances Holdings, Boosting ETFs While Trimming Kingstone Position.

Evernest’s Fidelity Enhanced International ETF stake totaled 350,237 shares after buying 80,971 shares in the fourth quarter, making the ETF its 10th-largest holding (about 3.0% of Evernest’s portfolio).
For CPS Technologies (CPSH), the filings-linked coverage cited multiple rating downgrades: Wall Street Zen cut the stock from “hold” to “sell” (May 9) and Zacks reduced it from “hold” to “strong sell” (May 6).
Evernest’s Kingstone Companies (KINS) trim came alongside a reported insider transaction: director William L. Yankus sold 13,500 shares at an average $18.00 on April 16, reducing his ownership by 13.71% to 84,972 shares.
CPSH trading/liquidity context in the coverage included technical benchmarks: shares opened at $7.86, with a 50-day simple moving average of $5.86 and a 200-day simple moving average of $4.70; the stock’s 12-month range was $2.10 to $14.39.
Evernest Financial Advisors LLC added 80,971 shares of the Fidelity Enhanced International ETF (FENI) in the fourth quarter, bringing its total stake to 350,237 shares. The purchase made FENI the firm's 10th-largest holding, representing about 3.0% of its portfolio, according to Ticker Report.
The Carmel, Indiana-based registered investment advisor also opened a new position in CPS Technologies Corp. (CPSH), buying roughly 145,000 shares valued at about $449,000 — even as two major analyst firms issued fresh downgrades on the stock.
The FENI purchase reflects a clear push toward what analysts call "active-passive" hybrids — funds that use a quantitative model to find returns in international developed markets. Evernest also raised its stake in the Fairlead Tactical Sector ETF (TACE), keeping it among its larger holdings. The Fairlead ETF is managed by Katie Stockton, a technical analyst who uses trend-following signals to rotate between sectors.
The firm grew from roughly $400 million in assets at launch to about $960 million by 2026, according to InvestmentNews. The tilt toward liquid, transparent ETFs like FENI and TACE appears to be part of a broader shift away from concentrated single-stock risk.
Evernest's new $449,000 bet on CPS Technologies stands out because it went against the grain. Zacks Investment Research cut CPSH from "hold" to "strong sell" on May 6. Three days later, Wall Street Zen downgraded the stock from "hold" to "sell." Despite those warnings, Evernest bought in.
The stock's numbers tell a volatile story. CPSH opened at $7.86, with a 50-day moving average of $5.86 and a 200-day moving average of $4.70. Its 12-month range ran from $2.10 all the way to $14.39. Institutional investors who track the defense and aerospace supply chain view the company as a "deep value" play, according to AAII, focusing on its specialized materials rather than short-term price swings.
Evernest trimmed its position in Kingstone Companies (KINS) by 22.4%, selling roughly 47,500 shares. The move came at roughly the same time as an insider sale. Director William L. Yankus sold 13,500 shares on April 16 at an average price of $18.00. That sale cut his personal ownership by 13.71%, leaving him with 84,972 shares.
The parallel selling — by both the advisor and a company director — pointed to cooling sentiment around the small regional insurer. Rising claims costs hit property and casualty insurers hard in early 2024. Still, other institutional investors continued to adjust their exposure, with FJ Capital Management raising its KINS stake by 89.3% in the fourth quarter, according to Ticker Report.
Evernest's portfolio shifts did not happen in a vacuum. The firm spent years fighting a legal battle with its former backer, Sanctuary Wealth, after FINRA fined Sanctuary $60,000 in 2022 for mishandling private placements. Evernest invoked a buyback clause to go independent. The two sides settled their lawsuit in January 2025, according to InvestmentNews.
By May 2026, Focus Financial Partners announced that its subsidiary, Focus Partners Wealth LLC, would acquire Evernest, with the deal expected to close in the third quarter of 2026. The aggressive portfolio moves of 2024 — rotating into ETFs, taking a contrarian stance on CPSH, and trimming insurance exposure — now look like steps that helped position the firm for that sale.
Publishers
12
Articles
2
Reach
14